Lacticaseibacillus strain and uses thereof
BD2026035A0Pending Publication Date: 2026-07-12KERRY GRP SERVICES INT LTD
Patent Information
- Authority / Receiving Office
- BD · BD
- Patent Type
- Applications
- Current Assignee / Owner
- KERRY GRP SERVICES INT LTD
- Filing Date
- 2026-01-28
- Publication Date
- 2026-07-12
Abstract
The invention is in the field of biomedicine; and relates to Lacticaseibacillus paracasei subsp. tolerans, and a specific bacterial strain or a variant thereof, and their use in the treatment of insulin resistance syndrome, polycystic ovary syndrome, insulin resistance related infertility, gestational diabetes, obesity, and proinflammatory conditions. The invention also relates to a biologically pure culture, or the composition, or the pharmaceutical product, or the pharmaceutical composition, or the nutraceutical composition, or the food supplement, the feed, or the nutritional product comprising the specific bacterial strain or variant thereof, and a therapeutic method comprising administering the specific bacterial strain, or the biologically pure culture, or the composition, or the pharmaceutical product, or the pharmaceutical composition, or the nutraceutical composition, or the food supplement, the feed, or the nutritional product comprising the bacterial strain or a variant thereof.
Need to check novelty before this filing date? Find Prior Art